These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9346374)

  • 1. Interferon alpha in hepatitis C: a cytokine for reducing fibrosis progression.
    Poynard T
    Eur Cytokine Netw; 1997 Sep; 8(3):319-20. PubMed ID: 9346374
    [No Abstract]   [Full Text] [Related]  

  • 2. Further inquiry into treating hepatitis C with recombinant interferon alpha.
    Puoti C; Fuiano B; Annovazzi G; Pannullo A; Patane F
    Ital J Gastroenterol; 1992 Feb; 24(2):111. PubMed ID: 1576363
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
    Kuo A; Tan V; Lan B; Khalili M; Feng S; Roberts JP; Terrault NA
    Liver Transpl; 2008 Oct; 14(10):1491-7. PubMed ID: 18825708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy.
    Mels GC; Roffi L; Antonelli G; Bellati G; Pacchetti S; Di Nolfo MA; Panizzuti F; Moretti G; Piperno A; Pozzi M
    Prog Clin Biol Res; 1993; 382():359-64. PubMed ID: 8502704
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic viral hepatitis].
    Marcellin P; Metreau JM; Pol S; Zoulim F
    Ann Gastroenterol Hepatol (Paris); 1996; 32(2):85-7. PubMed ID: 8737503
    [No Abstract]   [Full Text] [Related]  

  • 6. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha.
    Bauduer F
    Am J Hematol; 1996 Nov; 53(3):209. PubMed ID: 8895702
    [No Abstract]   [Full Text] [Related]  

  • 7. [Should hepatitis C be treated? What are indications of treatment in chronic hepatitis C?].
    Pascal JP
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S70-9. PubMed ID: 9161517
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic hepatitis. 2: Treatment].
    Blum HE; Moradpour D
    Dtsch Med Wochenschr; 2001 Jul; 126(27):786-9; quiz 790-2. PubMed ID: 11486479
    [No Abstract]   [Full Text] [Related]  

  • 9. Managing patients with hepatitis C.
    Drug Ther Bull; 1993 Aug; 31(16):61-2. PubMed ID: 8375275
    [No Abstract]   [Full Text] [Related]  

  • 10. [The successful treatment of chronic active hepatitis due to hepatitis C viral infection with alpha-interferon and a cytokine complex (a clinical case)].
    Karpov VV; Krel' PE
    Ter Arkh; 1995; 67(5):84-5. PubMed ID: 7638792
    [No Abstract]   [Full Text] [Related]  

  • 11. Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?
    Lau GK
    J Hepatol; 2007 Jan; 46(1):6-8. PubMed ID: 17112628
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.
    Nguyen HV; Mollison LC; Taylor TW; Chubb SA; Yeap BB
    Intern Med J; 2006 Jun; 36(6):362-6. PubMed ID: 16732861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
    Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
    Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C: limits and dose regimen of interferon alfa.
    Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Which courses of chronic replicating hepatitis C should be treated with interferon?].
    Gerken G
    Internist (Berl); 1993 Sep; 34(9):875-6. PubMed ID: 8407206
    [No Abstract]   [Full Text] [Related]  

  • 17. Why we should treat chronic viral hepatitis.
    King PD
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract]   [Full Text] [Related]  

  • 18. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
    Shibata M; Yanaga K; Morizane T; Yanagawa T; Hirakawa M; Ueno Y; Esquivel CO; Mitamura K
    J Gastroenterol; 2003; 38(6):598-602. PubMed ID: 12858850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interferon-alpha and liver fibrosis in patients with chronic damage due to hepatitis C virus].
    Gonzalez-Huezo MS; Gallegos-Orozco JF
    Rev Gastroenterol Mex; 2003; 68(3):239-44. PubMed ID: 14702938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.
    Lin SM; Yu ML; Lee CM; Chien RN; Sheen IS; Chu CM; Liaw YF
    J Hepatol; 2007 Jan; 46(1):45-52. PubMed ID: 17107734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.